'김갑성' 기자의 전체기사
-
AESOP Technology announces DxPrime is now a qualified s…
SAN FRANCISCO, Oct. 21, 2025 -- DxPrime, an AI-powered solution designed to enhance diagnostic accuracy through real-time integrity analysis and automated code translation, is now available on Mayo Clinic Platform. Driven by AESOP Technology's Clinical Deep Reasoning Network Model, DxPrime customizes its insights based on specialty, gender, and clinical context to ensure diagnostic completeness and precision. It delivers explainable, real-time diagnostic feedback and automatically converts diagnoses into medical codes to reduce misses, delays, or inaccuracies throughout the process fro
- 김갑성 기자
- 2025-10-21 23:30
-
Charming Medical Limited Announces Pricing of Initial Public…
HONG KONG, Oct. 21, 2025 -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the pricing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share (the "Public Offering Price"). The Class A Ordinary Shares are expected to commence trading on the Nasdaq Capital Market on October 21, 2025, under the ticker symbol "
- 김갑성 기자
- 2025-10-21 23:00
-
JOY GROUP Completes Acquisition of Italian Dermatological Hair…
SHANGHAI, Oct. 21, 2025 -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion of its acquisition of Foltène, a dermatological hair care brand from Italy. Founded in Milan in 1944 by pharmaceutical researchers, Foltène is renowned for its scientific heritage and pioneering innovation. The brand developed two proprietary active complexes, Tricosaccaride® and Tricalgoxyl®, which are clinically proven to promote thicker, fuller, and healthier-looking hair. Foltène's core product portfolio
- 김갑성 기자
- 2025-10-21 22:00
-
GROWNSY Joins Babylist Beverly Hills Showroom to Bring Smarter Pa…
LOS ANGELES, Oct. 21, 2025 -- GROWNSY, a fast-growing baby care brand trusted by parents across the U.S. and beyond, successfully launched in-store at the Babylist Beverly Hills Showroom this past September. A Shared Vision for Modern Families GROWNSY and Babylist share a common goal: to make parenting smarter, simpler, and more joyful. Babylist provides parents with a trusted platform to discover products and build personalized registries, while GROWNSY delivers solutions designed to ease everyday challenges. "With Babylist reaching millions of expecting par
- 김갑성 기자
- 2025-10-21 21:00
-
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusio…
TAIPEI and SHANGHAI and SAN FRANCISCO, Oct. 21, 2025 -- HanchorBio today announced that its proprietary HCB101, a SIRPα/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled "ENGINEERED SIRPα VARIANTS AND METHODS OF USE THEREOF", the patent represents major international recognition for the company's innovative technology for immuno-oncology. Mechanism of Action and Novelty of HCB101: An Innovative Fusion Protein Design Developed using HanchorBio's proprietary FBDB
- 김갑성 기자
- 2025-10-21 19:00
-
HKSH Medical Group to Host Hong Kong's First Asia-Oceania…
[ 메디채널 김갑성 기자 ] Best Practice by World-class Experts in Proton Therapy Transforming Precision Cancer Management HONG KONG, Oct. 21, 2025 -- HKSH Medical Group (HKSH) introduced Hong Kong's only and the Greater Bay Area's first proton therapy system in 2023, after two decades of planning and preparation. Now that the HKSH Proton Therapy Centre has been in operation for two years, following the "Proton Therapy Joint Training Course" co-organised with the National Cancer Center in Beijing this June and the initiation of the ten-month "HKSH Cancer Centre Proton Therapy Tra
- 김갑성 기자
- 2025-10-21 16:02
-
Getinge Interim Report July-September 2025: High organic sale…
GOTHENBURG, Sweden, Oct. 21, 2025 -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher demand for ventilators, in the wake of an ongoing market consolidation. Order intake and sales of ECLS consumables were also significant. Both Life Science and
- 김갑성 기자
- 2025-10-21 14:45
-
Abbott and BIG CARiNG Group Launch Nationwide Influenza Aw…
KUALA LUMPUR, Malaysia, Oct. 21, 2025 -- Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one of Malaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness across Malaysia. The Influenza Awareness Program, running from 2025 to 2027, is designed to elevate public understanding of influenza and encourage proactive health management. This nationwide initiative reflects a shared commitment to improving community health outcomes through education, engagement, and accessible healthcare information. Through a phased rollo
- 김갑성 기자
- 2025-10-21 13:12
-
Biomom Partners with Kolmar BNH to Enhance "Biomom Snow" --…
SEOUL, South Korea, Oct. 21, 2025 -- Health supplement brand Biomom has renewed its flagship children's probiotic, "Biomom Snow," with enhanced quality and improved flavor. As part of the renewal, Biomom selected Kolmar BNH Co., Ltd. as its new manufacturing partner, reinforcing its commitment to consumer satisfaction and product innovation Biomom Snow contains 10 billion CFU probiotics per stick, using 19 strains certified by the Korean Ministry of Food and Drug Safety (MFDS). It also includes essential nutrients such as Vitamin B complex, Vitamin D, folic acid
- 김갑성 기자
- 2025-10-21 11:00
-
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a N…
TAIPEI and SAN DIEGO, Oct. 21, 2025 -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind reported that its latest AI model successfully generated and experimentally validated a new hypothesis for cancer treatment, calling it "a milestone for AI in science." Through large-scale analysis of tumor cell data and more than 4,000 potential drug candidates, DeepMind's model
- 김갑성 기자
- 2025-10-21 10:49
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-12_FRI
- ADSFF Mobilises Capital, Policy and Innovation to Drive the Next Era of Sustainability 02:42
- His Excellency affirmed that NDF has achieved significant international development milestones over the past fifty years, including more than USD 40 billion in assistance 01:35
- ZOWIE Elevates Esports Performance at Budapest Major 2025 01:00
- TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 00:21
- ACE Shutters Notorious Piracy Operations in India 00:01
- Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix® 00:00
- Gravity Launches Hybrid Casual Game 'Ragnarok Monster Kitchen' Worldwide! 00:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 12일 04시 20분